LIFECORE BIOMEDICAL, INC. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
LIFECORE BIOMEDICAL, INC. (LFCR) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost of $984.00 thousand as of 2023-05-28, per its 10-K filed 2024-03-20.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost · last filed 2024-03-20
- 2023-05-28: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $984.00K.
- 2022-05-29: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $880.00K.
- 2021-05-30: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $1.12M.
- 2020-05-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $904.00K.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost |
|---|---|
| 2023-05-28 | $984.00K 10-K · filed 2024-03-20 |
| 2022-05-29 | $880.00K 10-K · filed 2024-03-20 |
| 2021-05-30 | $1.12M 10-K · filed 2024-03-20 |
| 2020-05-31 | $904.00K 10-K · filed 2021-07-29 |
| 2019-05-26 | $979.00K 10-K · filed 2020-08-14 |
| 2018-05-27 | $1.25M 10-K · filed 2019-08-01 |
| 2017-05-28 | $2.03M 10-K · filed 2018-08-09 |
| 2016-05-29 | $1.44M 10-K/A · filed 2018-03-15 |
| 2015-05-31 | $662.00K 10-K · filed 2016-08-01 |
| 2014-05-25 | $723.00K 10-K · filed 2015-07-31 |
| 2013-05-26 | $621.00K 10-K · filed 2014-08-01 |
| 2012-05-27 | $981.00K 10-K · filed 2013-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |